Priming Of Mir-181a In Acute Myeloid Leukemia (Aml) To Increase Chemosensitivity: A Phase I Trial Of Lenalidomide (Len) Followed By Idarubicin And CytarabineWilliam Blum,Rebecca B. Klisovic,Alison Walker,Sebastian Schwind,Yao Jiang,Jiang Wang,Mitch A. Phelps,Susan Geyer,Steven M. Devine, Kathy Walsh,Sumithira Vasu,John Curfman,Larry J. Schaaf,Celia Garr,Cheryl Kefauver,John C. Byrd,Michael R. Grever,Ramiro Garzon,Guido MarcucciBLOOD(2012)引用 1|浏览20暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要